Home
Conditions
Hematopoietic and Lymphoid Cell Neoplasm

Clinical trial condition

Hematopoietic and Lymphoid Cell Neoplasm

Explore clinical trials studying Hematopoietic and Lymphoid Cell Neoplasm. Study availability and eligibility vary by location and protocol.

160 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hematopoietic and Lymphoid Cell Neoplasm trial results

Active, not recruiting

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)

NCT04439253

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

NCT05641961

Conditions: Childhood Cancer, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Active, not recruiting

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

NCT06303167

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Patient Reported Symptom Control With THC or CBD Use

NCT04875286

Conditions: Cancer Pain, Cancer-Associated Pain, Hematologic Diseases, +10 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665

Conditions: COVID-19, COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

NCT04439136

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

View all 1410 locations

View Trial Details

Active, not recruiting

A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy

NCT05173961

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

NCT02210078

Conditions: Cytomegaloviral Infection, Cytomegalovirus Infections, DNA Virus Infections, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

NCT04537871

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +32 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm trial results

Related conditions